We are live on
!
Find out more
FIG
Freed Investment Group Portfolio holdings
AUM
$131M
1-Year Est. Return
30.59%
This Fund
S&P 500
This Quarter
Est. Return
+0.32%
1 Year Est. Return
+30.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$2.32M
(+1.8%)
Cap. Flow
+$1.99M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
98.43%
Holding
16
New
2
Increased
6
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$915K |
| 2 |
PMV Pharmaceuticals
PMVP
|
+$794K |
| 3 |
Apple
AAPL
|
+$366K |
| 4 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
+$158K |
| 5 |
Citius Pharmaceuticals
CTXR
|
+$106K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$422K |
| 2 |
Amazon
AMZN
|
+$41.4K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.29K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.23% |
| 2 | Communication Services | 8.03% |
| 3 | Consumer Discretionary | 5.54% |
| 4 | Financials | 4.4% |
| 5 | Healthcare | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
| $43.7M | 33.28% |
777,052
+2,737
| +0.4% | +$158K |
|
|
2
iShares Core S&P 500 ETF
IVV
$881B
| $38.8M | 29.57% |
90,048
+2,065
| +2% | +$915K |
|
|
3
Apple
AAPL
$4.9T
| $8.38M | 6.39% |
59,199
+2,489
| +4% | +$366K |
|
|
4
Amazon
AMZN
$2.66T
| $7.27M | 5.54% |
44,260
-240
| -0.5% | -$41.4K |
|
5
Microsoft
MSFT
$2.93T
| $7.04M | 5.37% |
24,979
+219
| +0.9% | +$63.7K |
|
|
6
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
| $6.94M | 5.29% |
20,523
-1,209
| -6% | -$422K |
|
7
Visa
V
$682B
| $5.77M | 4.4% |
25,902
+192
| +0.7% | +$45K |
|
8
Alphabet (Google) Class C
GOOG
$4.22T
| $5.44M | 4.15% |
40,840
+40
| +0.1% | +$5.51K |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.23T
| $5.08M | 3.88% |
38,040
| – | – |
|
|
10
PMV Pharmaceuticals
PMVP
$71.5M
| $741K | 0.56% |
+24,880
| New | +$794K |
|
11
NVIDIA
NVDA
$4.91T
| $621K | 0.47% |
29,960
| – | – |
|
12
Johnson & Johnson
JNJ
$609B
| $526K | 0.4% |
3,259
| – | – |
|
|
CDAK
13
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $332K | 0.25% |
20,328
| – | – |
|
|
14
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $262K | 0.2% |
610
-12
| -2% | -$5.29K |
|
15
Vir Biotechnology
VIR
$1.59B
| $218K | 0.17% |
5,000
| – | – |
|
|
16
Citius Pharmaceuticals
CTXR
$13.6M
| $107K | 0.08% |
+2,116
| New | +$106K |
|
Similar funds
HC
DMPV
CSM
CGFI
BRC
RP
SVC
SCM
Freed Investment Group's Q3 2021 Portfolio in Review
As of Q3 2021, Freed Investment Group held 16 positions worth $131M, up 1.8% from $129M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Freed Investment Group's Q3 2021 filing shows 2 new, 6 increased and 3 reduced positions. Its largest new stake was PMV Pharmaceuticals: 24,880 shares worth $741K. The largest sale was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $422K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Freed Investment Group's largest Q3 2021 buy was PMV Pharmaceuticals: 24,880 shares worth $741K.
- Freed Investment Group added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $915K increase.
- Freed Investment Group's biggest Q3 2021 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $422K.
- Freed Investment Group's ten largest holdings make up 98% of its $131M portfolio in Q3 2021.
- Freed Investment Group opened 2 new positions and closed 0 in Q3 2021.
- Freed Investment Group's portfolio value rose 1.8% quarter-over-quarter to $131M.
Based on Freed Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.